Oxalate regulates crystal-cell adhesion and macrophage metabolism via JPT2/PI3K/AKT signaling to promote the progression of kidney stones

Qianlin Song; Chao Song; Xin Chen; Yunhe Xiong; Ziqi He; Xiaozhe Su; Jiawei Zhou; Hu Ke; Caitao Dong; Wenbiao Liao; Sixing Yang

doi:10.1016/j.jpha.2024.02.010

Volume 14 Issue 6

Jun. 2024

Turn off MathJax

Article Contents

Article Navigation > Journal of Pharmaceutical Analysis > 2024 > 14(6): 100956

Qianlin Song, Chao Song, Xin Chen, Yunhe Xiong, Ziqi He, Xiaozhe Su, Jiawei Zhou, Hu Ke, Caitao Dong, Wenbiao Liao, Sixing Yang. Oxalate regulates crystal-cell adhesion and macrophage metabolism via JPT2/PI3K/AKT signaling to promote the progression of kidney stones[J]. Journal of Pharmaceutical Analysis, 2024, 14(6): 100956. doi: 10.1016/j.jpha.2024.02.010

Citation:

Qianlin Song, Chao Song, Xin Chen, Yunhe Xiong, Ziqi He, Xiaozhe Su, Jiawei Zhou, Hu Ke, Caitao Dong, Wenbiao Liao, Sixing Yang. Oxalate regulates crystal-cell adhesion and macrophage metabolism via JPT2/PI3K/AKT signaling to promote the progression of kidney stones[J]. Journal of Pharmaceutical Analysis, 2024, 14(6): 100956. doi: 10.1016/j.jpha.2024.02.010

Citation:

Qianlin Song, Chao Song, Xin Chen, Yunhe Xiong, Ziqi He, Xiaozhe Su, Jiawei Zhou, Hu Ke, Caitao Dong, Wenbiao Liao, Sixing Yang. Oxalate regulates crystal-cell adhesion and macrophage metabolism via JPT2/PI3K/AKT signaling to promote the progression of kidney stones[J]. Journal of Pharmaceutical Analysis, 2024, 14(6): 100956. doi: 10.1016/j.jpha.2024.02.010

PDF( 7499 KB)

Oxalate regulates crystal-cell adhesion and macrophage metabolism via JPT2/PI3K/AKT signaling to promote the progression of kidney stones

doi: 10.1016/j.jpha.2024.02.010

a. Department of Urology, Renmin Hospital of Wuhan University, Wuhan, 430060, China;
b. Department of Obstetrics and Gynecology, Renmin Hospital of Wuhan University, Wuhan, 430060, China

Funds:

This work was supported by the National Natural Science Foundation of China (Grant Nos.: 82070723, and 82270797) and Nature Science Foundation of Hubei Province, China (Grant No.: 2022CFC020).

Received Date: Sep. 25, 2023
Accepted Date: Feb. 21, 2024
Rev Recd Date: Feb. 07, 2024
Publish Date: Feb. 27, 2024

Abstract

Abstract

Oxalate is an organic dicarboxylic acid that is a common component of plant foods. The kidneys are essential organs for oxalate excretion, but excessive oxalates may induce kidney stones. Jupiter microtubule associated homolog 2 (JPT2) is a critical molecule in Ca²⁺ mobilization, and its intrinsic mechanism in oxalate exposure and kidney stones remains unclear. This study aimed to reveal the mechanism of JPT2 in oxalate exposure and kidney stones. Genetic approaches were used to control JPT2 expression in cells and mice, and the JPT2 mechanism of action was analyzed using transcriptomics and untargeted metabolomics. The results showed that oxalate exposure triggered the upregulation of JPT2, which is involved in nicotinic acid adenine dinucleotide phosphate (NAADP)-mediated Ca²⁺ mobilization. Transcriptomic analysis revealed that cell adhesion and macrophage inflammatory polarization were inhibited by JPT2 knockdown, and these were dominated by phosphatidylinositol 3-kinase (PI3K)/AKT signaling, respectively. Untargeted metabolomics indicated that JPT2 knockdown inhibited the production of succinic acid semialdehyde (SSA) in macrophages. Furthermore, JPT2 deficiency in mice inhibited kidney stones mineralization. In conclusion, this study demonstrates that oxalate exposure facilitates kidney stones by promoting crystal-cell adhesion, and modulating macrophage metabolism and inflammatory polarization via JPT2/PI3K/AKT signaling.
- Oxalate,
- Kidney stones,
- JPT2,
- Crystal-cell adhesion,
- Immunoregulation

FullText(HTML)

References(58)

References

[1]	M. Bargagli, M.C. Tio, S.S. Waikar, et al., Dietary oxalate intake and kidney outcomes, Nutrients 12(2020), 2673.
[2]	B. Misiewicz, D. Mencer, W. Terzaghi, et al., Analytical methods for oxalate quantification:The ubiquitous organic anion, Molecules 28(2023), 3206.
[3]	C. Li, L. Wang, M. Yuan, et al., A new route for indirect mineralization of carbon dioxide-sodium oxalate as a detergent builder, Sci. Rep. 9(2019), 12852.
[4]	Y. Wang, C.J.E. Davey, K. van der Maas, et al., Biodegradability of novel high Tg poly (isosorbide-co-1,6-hexanediol) oxalate polyester in soil and marine environments, Sci. Total Environ. 815(2022), 152781.
[5]	M. Liebman, I.A. Al-Wahsh, Probiotics and other key determinants of dietary oxalate absorption, Adv. Nutr. 2(2011)254-260.
[6]	C. Witting, C.B. Langman, D. Assimos, et al., Pathophysiology and treatment of enteric hyperoxaluria, Clin. J. Am. Soc. Nephrol. 16(2021)487-495.
[7]	C. Thongprayoon, A.E. Krambeck, A.D. Rule, Determining the true burden of kidney stone disease, Nat. Rev. Nephrol. 16(2020)736-746.
[8]	M.S.C. Morgan, M.S. Pearle, Medical management of renal stones, BMJ 352(2016), i52.
[9]	Y. Yang, Y. Deng, Y. Wang, Major geogenic factors controlling geographical clustering of urolithiasis in China, Sci. Total Environ. 571(2016)1164-1171.
[10]	G.S. Gunaratne, E. Brailoiu, S. He, et al., Essential requirement for JPT2 in NAADP-evoked Ca²⁺signaling, Sci. Signal. 14(2021), eabd5605.
[11]	T.F. Walseth, A.H. Guse, NAADP:From discovery to mechanism, Front. Immunol. 12(2021), 703326.
[12]	J.S. Marchant, G.S. Gunaratne, X. Cai, et al., NAADP-binding proteins find their identity, Trends Biochem. Sci. 47(2022)235-249.
[13]	M.J. Berridge, M.D. Bootman, H.L. Roderick, Calcium signalling:Dynamics, homeostasis and remodelling, Nat. Rev. Mol. Cell Biol. 4(2003)517-529.
[14]	A.J. Branco, A.S. Vattamparambil, G.M. Landry, Lead (Pb²⁺)-induced calcium oxalate crystallization ex vivo is ameliorated via inositol 1,4,5-trisphosphate receptor (InsP3R) knockdown in a Drosophila melanogaster model of nephrolithiasis, Environ. Toxicol. Pharmacol. 87(2021), 103695.
[15]	Q. Song, C. Song, X. Chen, et al., FKBP5 deficiency attenuates calcium oxalate kidney stone formation by suppressing cell-crystal adhesion, apoptosis and macrophage M1 polarization via inhibition of NF-κB signaling, Cell Mol. Life Sci. 80(2023), 301.
[16]	X. Feng, L. Chen, W. Guo, et al., Graphene oxide induces p62/SQSTM-dependent apoptosis through the impairment of autophagic flux and lysosomal dysfunction in PC12 cells, Acta Biomater. 81(2018)278-292.
[17]	A.W. Miller, D. Choy, K.L. Penniston, et al., Inhibition of urinary stone disease by a multi-species bacterial network ensures healthy oxalate homeostasis, Kidney Int. 96(2019)180-188.
[18]	K.Y. Renkema, K. Lee, C.N. Topala, et al., TRPV5 gene polymorphisms in renal hypercalciuria, Nephrol. Dial. Transplant. 24(2009)1919-1924.
[19]	W. Wang, B. Qian, C. Zhao, et al., Sublytic C5β-9 Induces CCL3/4 production and macrophage accumulation in thy-1N rats via PKC-α/p65/IRF-8 axis, Int. J. Biol. Sci. 18(2022)3178-3193.
[20]	H. Liu, X. Yang, K. Tang, et al., Sulforaphane elicts dual therapeutic effects on renal inflammatory injury and crystal deposition in calcium oxalate nephrocalcinosis, Theranostics. 10(2020)7319-7334.
[21]	A.H. Guse, B.P. Diercks, Integration of nicotinic acid adenine dinucleotide phosphate (NAADP)-dependent calcium signalling, J. Physiol. 596(2018)2735-2743.
[22]	F. Gu, A. Kruger, H.G. Roggenkamp, et al., Dual NADPH oxidases DUOX1 and DUOX2 synthesize NAADP and are necessary for Ca²⁺signaling during T cell activation, Sci. Signal. 14(2021), eabe3800.
[23]	C.D. Haffner, J.D. Becherer, E.E. Boros, et al., Discovery, synthesis, and biological evaluation of thiazoloquin (az) olin (on) es as Potent CD38 Inhibitors, J. Med. Chem. 58(2015)3548-3571.
[24]	W. Li, F. Yan, H. Zhou, et al., P. aeruginosa lipopolysaccharide-induced MUC5AC and CLCA3 expression is partly through Duox1 in vitro and in vivo, PLoS One 8(2013), e63945.
[25]	L. Zhong, M.J. Simard, J. Huot, Endothelial microRNAs regulating the NF-κB pathway and cell adhesion molecules during inflammation, FASEB J. 32(2018)4070-4084.
[26]	M. Rafat, L.S. Rotenstein, J.L. Hu, et al., Engineered endothelial cell adhesion via VCAM1 and E-selectin antibody-presenting alginate hydrogels, Acta Biomater. 8(2012)2697-2703.
[27]	S.R. Khan, B.K. Canales, P.R. Dominguez-Gutierrez, Randall's plaque and calcium oxalate stone formation:Role for immunity and inflammation, Nat. Rev. Nephrol. 17(2021)417-433.
[28]	J. Xue, S.V. Schmidt, J. Sander, et al., Transcriptome-based network analysis reveals a spectrum model of human macrophage activation, Immunity 40(2014)274-288.
[29]	S. Singh, D. Anshita, V. Ravichandiran, MCP-1:Function, regulation, and involvement in disease, Int. Immunopharmacol. 101(2021), 107598.
[30]	X. Li, W. Yao, Y. Yuan, et al., Targeting of tumour-infiltrating macrophages via CCL2/CCR2 signalling as a therapeutic strategy against hepatocellular carcinoma, Gut. 66(2017)157-167.
[31]	A.Y. Sun, B. Hinck, B.R. Cohen, et al., Inflammatory cytokines in the papillary tips and urine of nephrolithiasis patients, J. Endourol. 32(2018)236-244.
[32]	I. Conti, B.J. Rollins, CCL2(monocyte chemoattractant protein-1) and cancer, Semin. Cancer Biol. 14(2004)149-154.
[33]	J. Wang, K. Hu, X. Cai, et al., Targeting PI3K/AKT signaling for treatment of idiopathic pulmonary fibrosis, Acta Pharm. Sin. B. 12(2022)18-32.
[34]	J. Yang, J. Nie, X. Ma, et al., Targeting PI3K in cancer:mechanisms and advances in clinical trials, Mol. Cancer. 18(2019), 26.
[35]	X. Li, W. Chen, P. Li, et al., Follicular stimulating hormone accelerates atherogenesis by increasing endothelial VCAM-1 expression, Theranostics. 7(2017)4671-4688.
[36]	T. Kasemsuk, S. Phuagkhaopong, R. Yubolphan, et al., Cadmium induces CCL2 production in glioblastoma cells via activation of MAPK, PI3K, and PKC pathways, J. Immunotoxicol. 17(2020)186-193.
[37]	J. Yan, T. Horng, Lipid metabolism in regulation of macrophage functions, Trends Cell Biol. 30(2020)979-989.
[38]	J. Van den Bossche, L.A. O'Neill, D. Menon, Macrophage immunometabolism:Where are we (going)?, Trends Immunol. 38(2017)395-406.
[39]	W. He, A. Heinz, D. Jahn, et al., Complexity of macrophage metabolism in infection, Curr. Opin. Biotechnol. 68(2021)231-239.
[40]	A. Besse, P. Wu, F. Bruni, et al., The GABA transaminase, ABAT, is essential for mitochondrial nucleoside metabolism, Cell Metab. 21(2015)417-427.
[41]	P. Malaspina, M.J. Picklo, C. Jakobs, et al., Comparative genomics of aldehyde dehydrogenase 5a1(succinate semialdehyde dehydrogenase) and accumulation of gamma-hydroxybutyrate associated with its deficiency, Hum. Genomics. 3(2009)106-120.
[42]	E.L. Mills, B. Kelly, A. Logan, et al., Succinate dehydrogenase supports metabolic repurposing of mitochondria to drive inflammatory macrophages, Cell 167(2016)457-470 e13.
[43]	G.M. Tannahill, A.M. Curtis, J. Adamik, et al., Succinate is an inflammatory signal that induces IL-1β through HIF-1α, Nature 496(2013)238-242.
[44]	C.L. Ibeh, A.J. Yiu, Y.L. Kanaras, et al., Evidence for a regulated Ca²⁺entry in proximal tubular cells and its implication in calcium stone formation, J. Cell Sci. 132(2019), jcs225268.
[45]	S. Shin, C.L. Ibeh, E. Awuah Boadi, et al., Hypercalciuria switches Ca²⁺signaling in proximal tubular cells, induces oxidative damage to promote calcium nephrolithiasis, Genes Dis. 9(2021)531-548.
[46]	S. Patel, G.S. Gunaratne, J.S. Marchant, et al., NAADP receptors:A one-two, Cell Calcium 100(2021), 102478.
[47]	S.R. Khan, M.S. Pearle, W.G. Robertson, et al., Kidney stones, Nat. Rev. Dis. Primers 2(2016), 16008.
[48]	Y. Li, X. Lu, Z. Yu, et al., Meta-data analysis of kidney stone disease highlights ATP1A1 involvement in renal crystal formation, Redox Biol. 61(2023), 102648.
[49]	X. Sheng, T. Jung, J.A. Wesson, et al., Adhesion at calcium oxalate crystal surfaces and the effect of urinary constituents, Proc. Natl. Acad. Sci. USA 102(2005)267-272.
[50]	J.A. Boyce, E.A. Mellor, B. Perkins, et al., Human mast cell progenitors use alpha4-integrin, VCAM-1, and PSGL-1 E-selectin for adhesive interactions with human vascular endothelium under flow conditions, Blood 99(2002)2890-2896.
[51]	R.N. Liu, D.M. Zou, M.Y. Tian, et al., Effect of magnesium ammonium phosphate on the expression of adhesion molecules in sheep renal tubular epithelial cells, Res. Vet. Sci. 138(2021)167-177.
[52]	A. Okada, T. Yasui, S. Hamamoto, et al., Genome-wide analysis of genes related to kidney stone formation and elimination in the calcium oxalate nephrolithiasis model mouse:Detection of stone-preventive factors and involvement of macrophage activity, J. Bone Miner. Res. 24(2009), 908-924.
[53]	A. Okada, T. Yasui, Y. Fujii, et al., Renal macrophage migration and crystal phagocytosis via inflammatory-related gene expression during kidney stone formation and elimination in mice:Detection by association analysis of stone-related gene expression and microstructural observation, J. Bone Miner. Res. 25(2010)2701-2711.
[54]	C. Wei, C. Yang, S. Wang, et al., Crosstalk between cancer cells and tumor associated macrophages is required for mesenchymal circulating tumor cell-mediated colorectal cancer metastasis, Mol. Cancer 18(2019), 64.
[55]	Y. Nio, T. Yamauchi, M. Iwabu, et al., Monocyte chemoattractant protein-1(MCP-1) deficiency enhances alternatively activated M2 macrophages and ameliorates insulin resistance and fatty liver in lipoatrophic diabetic A-ZIP transgenic mice, Diabetologia. 55(2012)3350-3358.
[56]	Y. Si, L. Liu, J. Cheng, et al., Oral hydrogen-rich water alleviates oxalate-induced kidney injury by suppressing oxidative stress, inflammation, and fibrosis, Front. Med. 8(2021), 713536.
[57]	L.A.J. O'Neill, E.J. Pearce, Immunometabolism governs dendritic cell and macrophage function, J. Exp. Med. 213(2016)15-23.
[58]	P.S. Liu, H. Wang, X. Li, et al., α-ketoglutarate orchestrates macrophage activation through metabolic and epigenetic reprogramming, Nat. Immunol. 18(2017)985-994.